Our results revealed that CD163-ZEB1 expression (Fig. 6E), CD163-DNMT1 expression (Fig. 6F) and ZEB1-DNMT1 expression (Fig. 6G) were positively correlated in breast cancer patients. This evidence concerns the gene CD163 and breast carcinoma.